A model of cancer stem cells derived from mouse induced pluripotent stem cells.
about
Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC InhibitionInduction of cancer stem cell properties in colon cancer cells by defined factorsAdvances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells TechnologiesInsights into the Nanog gene: A propeller for stemness in primitive stem cellsIn vitro models of cancer stem cells and clinical applicationsConcise Review: Induced Pluripotent Stem Cells as New Model Systems in OncologyA synthetic small molecule for rapid induction of multiple pluripotency genes in mouse embryonic fibroblastsWithaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cellsClinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles.Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cellsG protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinomaCancer stem cells maintain a hierarchy of differentiation by creating their nicheThe crossroads between cancer stem cells and aging.Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer.Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.Stacking the DEK: from chromatin topology to cancer stem cells.Characterization of Gene Expression Patterns among Artificially Developed Cancer Stem Cells Using Spherical Self-Organizing Map.iPSC-derived cancer stem cells provide a model of tumor vasculature.Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells.Mouse induced pluripotent stem cell microenvironment generates epithelial-mesenchymal transition in mouse Lewis lung cancer cells.A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).Recent technological advances in using mouse models to study ovarian cancer.Piwil2-transfected human fibroblasts are cancer stem cell-like and genetically unstable.Convergent mechanisms in pluripotent stem cells and cancer: implications for stem cell engineering.Induced neural lineage cells as repair kits: so close, yet so far away.Strategies to modulate heritable epigenetic defects in cellular machinery: lessons from nature.Cancer stem cells converted from pluripotent stem cells and the cancerous niche.The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers.Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment.The Stem Cell Connection of Pituitary Tumors.Iron depletion is a novel therapeutic strategy to target cancer stem cells.Up-Regulation of PI 3-Kinases and the Activation of PI3K-Akt Signaling Pathway in Cancer Stem-Like Cells Through DNA Hypomethylation Mediated by the Cancer Microenvironment.Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium
P2860
Q27026986-F7C4C37C-5F25-4B0E-AA0D-4099B7496F52Q27320228-BC1B7D18-3A13-414C-905E-6A140DE25028Q28071879-69A365E0-04E1-4BE4-AA5B-8B169F0D620AQ28073695-A8FA8A19-D059-4925-8B11-4A0C4CCCCEDEQ28076101-F1B7FCA9-5CAE-4993-BECD-2C1EF2A12D05Q28080945-0377253B-6D5A-4FFD-831A-3E41384C6B37Q28272175-C901A626-8FC3-4878-AD04-E9FA8437655AQ28543359-8EDBFF37-ACA9-4957-AF54-E9021E65B8EEQ33574875-FCF80D38-C7AC-4E5F-9A4E-E640A853DA3FQ33935224-9464201B-D4D1-404F-8FBA-1204C8B3C963Q34473615-A84DBB25-997B-4300-BCB0-3918C5FE1A81Q34674548-6331C824-4E40-4704-985E-80689D450C6FQ34770478-C5762756-CFD1-42FB-B724-08010589915CQ35566484-B645BDE7-ED8A-4123-87B9-ED0CA25BEBD5Q36413420-E69CE434-282B-44CE-9A28-6AB3602839F1Q36420378-D87847DC-B123-45D5-8CDA-F561AFCFD415Q36604651-5A07E96B-F6C3-4174-A8BE-2BBA2958EED6Q37183311-3B9BE3F3-88A7-467F-911F-723D39E7819CQ37298276-F65756CD-FFA7-49DB-8515-975664E9135CQ37299588-24D14992-272A-46EB-84D5-B8545349D5FFQ37516313-2BAAC761-6CAB-4B6E-A2DC-09287E573DEBQ37545090-9CAF365F-677D-40DE-A740-9506927DD4E2Q37581537-9DAF2087-C167-47F1-96E6-554074C65171Q37707085-D62AD38E-1506-44C0-8475-6AF5C67761F9Q38082494-1168276F-2061-4161-B3F0-C46E80D0BF25Q38163443-8082F812-9C12-43B5-A5EE-00C221C1876FQ38166178-136567EB-0A26-4CD2-8554-31326B8B2754Q38235250-53853C0F-9DCA-4115-A52B-0E1D29D614B1Q38242892-DE0655CB-2155-4722-8AB5-5F569D29DE4BQ38724218-C125E78C-D195-40A6-B670-00C01F1A6554Q38840374-5AA6D1CF-50FD-46C7-9965-6168B3E93D83Q39144729-512BEBFA-40BE-4778-A99C-AFBB9656538BQ42007848-610BAE7F-7CA8-409D-8F7A-2A2F193B353EQ47122908-5DFE5E69-EE60-4604-9D32-A32898503224Q47152171-CD67C0B0-9098-406C-835F-12F333476AD4Q52721325-766EC1B3-CA1D-4B75-B602-2DD70975CF3CQ58804584-D27787FC-E1D8-4A3D-8E65-CF10DE169805
P2860
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@ast
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@en
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@nl
type
label
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@ast
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@en
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@nl
prefLabel
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@ast
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@en
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@nl
P2093
P2860
P1433
P1476
A model of cancer stem cells derived from mouse induced pluripotent stem cells.
@en
P2093
Akifumi Mizutani
Arun Vaidyanath
David S Salomon
Guoliang Jin
Mary J C Hendrix
Masashi Okada
Takayuki Kudoh
Tomonari Kasai
P2860
P304
P356
10.1371/JOURNAL.PONE.0033544
P407
P577
2012-04-12T00:00:00Z